Stockreport

Eli Lilly's Taltz-Zepbound combo scores in late-stage PsA study [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF During the Phase IIIb TOGETHER-PsA study (NCT06588296), the concomitant use of Zepbound-Taltz significantly increased the percentage of patients (31.7%) exhibiting at l [Read more]